HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function

In an effort to clear persistent HIV infection and achieve a durable therapy-free remission of HIV disease, extensive pre-clinical studies and early pilot clinical trials are underway to develop and test agents that can reverse latent HIV infection and present viral antigen to the immune system for...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, Carolina, Spivak, Adam M., Soriano-Sarabia, Natalia, Checkley, Mary Ann, Barker, Edward, Karn, Jonathan, Planelles, Vicente, Margolis, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030263/
https://www.ncbi.nlm.nih.gov/pubmed/27708642
http://dx.doi.org/10.3389/fimmu.2016.00356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030263/
https://www.ncbi.nlm.nih.gov/pubmed/27708642
http://dx.doi.org/10.3389/fimmu.2016.00356

Ejemplares similares